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Background
Mutations in RYR1 (ryanodine receptor type 1) are linked
to the majority of malignant hyperthermia (MH) families
(75%) and some cases of Exertional Heat Stroke. Two
CACNA1S variants associated with MH have been func-
tionally characterised. Historically, because of the large
size of the RYR1 gene, MH families were screened for 31
diagnostic RYR1 variants only. Methods based on PCR
and Sanger sequencing were used. The new opportunity
arose since next generation sequencing techniques became
available. With this technique sequencing is considerably
quicker therefore even long gene sequences such as RYR1
can be easily screened for variations.
Material and methods
We used Next-Generation Sequencing to look for cod-
ing sequence non-synonymous variants of RYR1 and
CACNA1S. We applied two different target enrichment
methods, Long-Range PCR and HaloPlex (Agilent), to
be able to focus on particular regions of the genome.
Results
In our study we included a group of 80 unrelated MHS
individuals who were previously screened for diagnostic
mutations in RYR1 and were found negative. Another
group consisted of discordant individuals, whose in vitro
contracture test (IVCT) phenotype was at odds with
their genotype for a familial diagnostic RYR1 mutation.
The third studied cohort (n=38) were Exertional Heat
Stroke patients, IVCT tested susceptible or normal.
Conclusions
Our results illustrate that Next Generation Sequencing
provides broad genetic information quicker and at lower
cost than conventional approaches. To improve under-
standing of malignant hyperthermia genetics, screening
of susceptible individuals only for a limited number of
diagnostic RYR1 variants is not sufficient. Studying the
full length of RYR1 and CACNA1S coding sequence
may also resolve some phenotype/genotype discordant
cases. Finally, Next Generation Sequencing techniques
provide opportunities for studying larger gDNA frag-
ments or the whole genome, which may result in disco-
vering some other genes linked to MH.
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